Daniel-Anibal Garcia Diego, president of the Spanish Haemophilia Federation (FEDHEMO), discusses the current situation of haemophilia treatment and healthcare coverage in Spain, as well as the unique challenges created by the autonomous regions of the country. He also gives insight into FEDHEMO’s ongoing initiatives and future objectives.
Spain is in the top tier of countries in terms of treatment [for haemophilia] and we are one of the leading countries in Europe for human haemophilia patients in clinical trials for new drugs.
